Lap-Band Gains Panel Support For Use In Less Obese, Less Sick Patients

An FDA panel has cleared the path for the agency to approve an expanded indication for Allergan's Lap-Band surgical obesity treatment to include at least 27 million additional people.

More from Archive

More from Medtech Insight